COMMON SHARES PURCHASE AGREEMENTCommon Shares Purchase Agreement • May 15th, 2025 • GT Biopharma, Inc. • Pharmaceutical preparations • New York
This COMMON SHARES PURCHASE AGREEMENT is made and entered into as of May 14, 2025 (this “Agreement”), by and between Five Narrow Lane, L.P., a Delaware limited partnership And/or its assignee and Bristol Capital, LLC, a Delaware limited liability company and/or its assignee (each an “Investor” and together, the “Investors”), and GT Biopharma, Inc. a Delaware corporation (the “Company”).
COMMON SHARES PURCHASE AGREEMENTCommon Shares Purchase Agreement • March 31st, 2025 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations • New York
This COMMON SHARES PURCHASE AGREEMENT is made and entered into as of March 28, 2025 (this “Agreement”), by and between Alpha Capital Anstalt, a Liechtenstein Anstalt (the “Investor”), and NLS Pharmaceutics Ltd., a corporation incorporated under the laws of Switzerland (the “Company”).
Certain confidential information contained in this document, marked by [***], has been omitted because Roivant Sciences Ltd. (the “Company”) has determined that the information (i) is not material and (ii) contains personal information. COMMON SHARES...Common Shares Purchase Agreement • February 14th, 2022 • Roivant Sciences Ltd. • Pharmaceutical preparations • New York
This COMMON SHARES PURCHASE AGREEMENT is made and entered into as of February 14, 2022 (this “Agreement”), by and between CF Principal Investments LLC, a Delaware limited liability company (the “Investor”), and Roivant Sciences Ltd., a Bermuda exempted company limited by shares (the “Company”).